TORONTO, 22 August 2024 /CNW/ – The Fatty Liver Alliance is calling on all Canadians to support an important petition calling on Madrigal Pharmaceuticals to apply to Health Canada for approval of Rezdiffra, the first and only drug approved to treat MASH, a severe and progressive form of fatty liver disease. An estimated 38% of […]